Maharashtra Herald

Shingles Market Trends, Opportunities, Challenges, Recent Developments, Leading Companies, Emerging Therapies, and Epidemiology Forecast

 Breaking News
  • No posts were found

Shingles Market Trends, Opportunities, Challenges, Recent Developments, Leading Companies, Emerging Therapies, and Epidemiology Forecast

July 20
22:44 2021
Delveinsight Business Research LLP

DelveInsight’s “Shingles Market Insights, Epidemiology, and Market Forecast 2030” report delivers an in-depth understanding of the historical and forecasted epidemiology as well as the Shingles Market Size and Share in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.

Shingles, also known as herpes zoster (HZ), is a viral infection caused by the chickenpox virus, varicella-zoster virus (VZV). Herpes zoster results from activation of the virus, which in many instances has remained latent for years following a primary chickenpox infection. Once active, the virus travels along a nerve to the skin and causes a rash.

The signs and symptoms of herpes zoster are usually distinctive enough to make an accurate clinical diagnosis once the rash has appeared. If characteristic blisters appear in the typical pattern (on a strip of skin representing a dermatome), the diagnosis is clear. However, diagnosis of herpes zoster might not be possible in the absence of a rash (i.e., before rash or in cases of zoster without rash). 

The Shingles Market Research Report covers emerging drugs, current treatment practices, market share of the individual therapies, current and forecasted Shingles market Size from 2017 to 2030 segmented by seven major markets. 

The report provides a detailed current Shingles treatment practice/algorithm, market drivers, market barriers, and unmet medical needs to curate the best of the opportunities and assess the underlying potential of the market. 

Shingles Market

Shingles Market Key Facts

  • According to Center for Disease Control and Prevention (CDC), almost 1 out of 3 people in the United States are at risk of developing shingles in their lifetime. An estimated one million cases of herpes zoster occur annually in the US. Additionally, the incidence for HZ is approximately 4 cases per 1,000 US population annually while the incidence among people 60 years and older is about 1 case per 100 US population annually.

  • As per study conducted by Takao et al. (2015) titled “Incidences of Herpes Zoster and Postherpetic Neuralgia in Japanese Adults Aged 50 Years and Older From a Community-based Prospective Cohort Study: The SHEZ Study”, the incidence of HZ was 10.9/1,000 person-years (men: 8.5/1,000 person-years; women: 12.8/1,000 person-years) and was significantly higher in women than in men.

Key Benefits of Shingles Market Report

  • The market report provides an in-depth analysis of Shingles Market Size, Share, Trend, and Epidemiology Forecast till 2030 in the seven major markets (i.e. the United States, EU5 (Germany, Italy, Spain, France, and the UK) and Japan.

  • The report will help in developing business strategies by understanding the Shingles Market Trends, recent developments, key players, and future market competition that will shape and drive the market growth in the upcoming years.

  • The market report covers Shingles current treatment practices, emerging drugs, market share of the individual therapies in the seven major markets.

  • The report provides a detailed assessment of the Shingles market in terms of market drivers & barriers, unmet needs, market opportunities, patient population, detailed comparative analysis of pipeline products including clinical and non-clinical stage products, and other factors. 

Shingles Market 

Shingles market size is expected to increase during the forecast period owing to the rise in the number of incident cases in the 7MM.

The market outlook section of the report helps to build a detailed comprehension of the historic, current, and forecasted Shingles market size and share by analyzing the impact of current therapies on the market, unmet needs, drivers, and barriers, and demand for better technology.

The report gives a thorough detail of the Shingles market trend of each marketed drug and late-stage pipeline therapy by evaluating their impact based on the annual cost of therapy, inclusion and exclusion criteria, mechanism of action, increasing patient pool, covered patient segment, expected launch year, competition with other therapies, brand value, their impact on the market and view of the key opinion leaders.

Get FREE sample copy at:

Shingles Epidemiology

The epidemiology section covers insights about the historical and current Shingles patient pool and forecasted trends for every seven major countries from 2017 to 2030. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. The epidemiology section also provides the diagnosed patient pool and their trends along with assumptions undertaken.  

Shingles Drugs Uptake and Pipeline Development Activities

The drugs uptake section focuses on the rate of uptake of the potential drugs recently launched in the Shingles market or expected to get launched in the market during the study period. The analysis covers Shingles market uptake by drugs; patient uptake by therapies; and sales of each drug.   

Report’s Drugs Uptake section helps in understanding the drugs with the most rapid uptake, reasons behind the maximal use of new drugs and allow the comparison of the drugs on the basis of market share and size which again will be useful in investigating factors important in market uptake and in making financial and regulatory decisions.

The report also covers the Shingles Pipeline Development Activities and provides valuable insights about different therapeutic candidates in Phase II, and Phase III stages and the key companies in the market involved in developing targeted therapeutics. It also analyses the recent Development such as collaborations, acquisitions, and mergers, licensing patent details, and other information for emerging therapies.

There are a few players involved in the development of therapies for the Shingles. These therapies are under early phase clinical development and the launch of these therapies is expected during the forecast period.

Shingles Companies involved in the therapeutics development includes:

  • Curevo 

  • Novartis

  • Maruho

  • Nobelpharma 

  • NanoViricides

  • GlaxoSmithKline

And many others.

Request for Sample @ Shingles Therapeutics Market Trends Analysis

Shingles Therapies covered in the report include:

  • Fostoin

  • CRV-101

  • NV-HHV-101

And many more.

Table of Content

1. Key Insights

2. Executive Summary 

3. Shingles Competitive Intelligence Analysis

4. Shingles Market Overview at a Glance

5. Shingles Disease Background and Overview

6. Shingles Patient Journey

7. Shingles Epidemiology and Patient Population

8. Shingles Treatment Algorithm, Current Treatment, and Medical Practices

9. Shingles Unmet Needs

10. Key Endpoints of Shingles Treatment

11. Shingles Marketed Products

12. Shingles Emerging Therapies

13. Shingles Seven Major Market Analysis

14. Attribute Analysis

15. Shingles Market Outlook (7 major markets)

16. Shingles Access and Reimbursement Overview

17. KOL Views on the Shingles Market.

18. Shingles Market Drivers

19. Shingles Market Barriers

20. Appendix

21. DelveInsight Capabilities

22. Disclaimer

*The table of contents is not exhaustive; the final content may vary. 

Get FREE sample copy at:

Latest Blogs By DelveInsight

Companies in FemTech Market

The women’s health market or more preferably FemTech market is booming with the advancements in technology as women shifted their rationale towards using technology and AI for their health benefits. Alternatively, many startups are also taking an interest in the domain to utilize the business opportunities in the female care segment and to capture the market share. 

Skin Cancer Treatment Therapies

Currently, some of the key companies in the Skin Cancer market focussing to offer potential treatment options include Pellepharm, Medivir, Regeneron/Sanofi, Morphogenesis, NantKwest, Kartos Therapeutics, Incyte Corporation, Bristol Myers Squibb, Nektar, Immutep, Partner Therapeutics, Idera Pharmaceuticals, Oncolys BioPharma, Iovance Biotherapeutics, Hemispherx Biopharma, Infinity Pharmaceuticals, Spring Bank Pharmaceuticals, and others. In the coming years, the improvement in the treatment regimens, diagnosis methodologies, rise in awareness, and incremental healthcare spending across the world are expected to improve the skin cancer treatment dynamics. 

About DelveInsight
DelveInsight is a leading Business Consultant, and Market Research Firm focused exclusively on life sciences. It supports pharma companies by providing end-to-end comprehensive solutions to improve their performance.

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Shruti Thakur
Email: Send Email
Phone: +919650213330
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: NV
Country: United States